【摘要】 目的 观察中医托法辨证治疗社区获得性肺炎的临床疗效。方法 选取94例社区获得性肺炎（痰热壅肺证）患者，随机分为观察组与对照组各47例。对照组采用西医常规治疗；观察组在对照组治疗基础上，采用中医托法代表方透脓散加减口服。比较两组中医证候疗效、炎症指标[白细胞计数（WBC）、中性粒细胞百分率（NEU%）、淋巴细胞百分率（LYM%）、C反应蛋白（CRP）]、肺部CT吸收情况、住院天数、住院费用及两组不良反应。结果 观察组中医证候疗效优于对照组（P<0.05）;NEU%下降幅度大于对照组（P<0.05）,LYM%上升幅度大于对照组（P<0.05）；肺部CT吸收情况优于对照组（P<0.05）；住院天数短于对照组（P<0.05），两组患者住院费用差异无统计学意义（P > 0.05）；两组均无不良反应发生。结论 中医托法辨证治疗社区获得性肺炎能改善症状，降低炎症反应，调节免疫力，促进炎症吸收，缩短住院天数，且治疗安全性良好。更多还原

【Abstract】 Objective:To observe the clinical efficacy of Tuofa theory based TCM syndrome differentiation treatment in patients with community-acquired pneumonia(CAP). Methods:94 patients with CAP of syndrome of phlegm-heat obstructing lung were randomly divided into an observation group and a control group,with 47 patients in each group. The control group received conventional western medical treatment,while the observation group was additionally treated with Modified Tounong Powder,which was a representative Tuofa formula and administered orally,based on syndrome differentiation. Outcomes including TCM syndrome efficacy,inflammatory markers[white blood cell count(WBC),neutrophil percentage(NEU%),lymphocyte percentage(LYM%),C-reactive protein(CRP)],lung CT absorption,length of hospital stay,hospitalization costs,and adverse reactions were compared between the two groups. Results:The observation group showed better TCM syndrome efficacy compared with the control group(P < 0.05). The decrease in NEU% was greater in the observation group(P < 0.05),and the increase in LYM% was also significantly greater(P < 0.05). Lung CT absorption was better in the observation group(P < 0.05).The length of hospital stay was shorter in the observation group(P < 0.05),while no significant difference was observed in hospitalization costs between the two groups(P > 0.05). No adverse reactions occurred in either group.Conclusion:TCM syndrome differentiation treatment based on the Tuofa theory can effectively improve symptoms,reduce inflammatory response,regulate immunity,promote absorption of pulmonary inflammation,and shorten hospital stay in patients with CAP,which demonstrates good safety and therapeutic efficacy.更多还原